Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Carcinoma, Oat Cell

tolvaptan has been researched along with Carcinoma, Oat Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grassi, P; Peverelli, G1
Benzing, T; Gross, P; Hensen, J; Mönig, H1

Reviews

1 review(s) available for tolvaptan and Carcinoma, Oat Cell

ArticleYear
[Practical approach to hyponatremia].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:34-35

    Topics: Aged; Benzazepines; Carcinoma, Small Cell; Combined Modality Therapy; Critical Pathways; Diagnosis, Differential; Drinking; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Sodium; Tolvaptan

2011

Other Studies

1 other study(ies) available for tolvaptan and Carcinoma, Oat Cell

ArticleYear
Pure small cell recurrent prostate cancer developing syndrome of inappropriate antidiuretic hormone secretion.
    Tumori, 2017, Nov-15, Volume: 103, Issue:Suppl. 1

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brachytherapy; Carcinoma, Small Cell; Humans; Inappropriate ADH Syndrome; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Syndrome; Tolvaptan

2017